The ROCOCO performance scoring system translates dosimetric differences into clinically relevant endpoints: Comparing IMPT to VMAT in an example pilocytic astrocytoma dataset

BACKGROUND AND PURPOSE: Proton therapy is expected to outperform photon-based treatment regarding organs at risk (OAR) sparing but to date there is no method to practically measure clinical benefit. Here, we introduce the novel ROCOCO Performance Scoring System (RPSS) translating dose differences in...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Transl Radiat Oncol
Glavni autori: in 't Ven, Lieke, Roelofs, Erik, Cubillos Mesías, Macarena, Compter, Inge, Klaver, Yvonne L.B., Smeenk, Robert Jan, Janssens, Geert O., Kaanders, Johannes H.A.M., Fajardo, Raquel Davila, Oldenburger, Foppe, de Ruysscher, Dirk, Troost, Esther G.C., Eekers, Daniëlle B.P.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2021
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7966832/
https://ncbi.nlm.nih.gov/pubmed/33748441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctro.2021.02.006
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items